Labelling and Clinical Performance of Human Leukocytes Labelled with <sup>99m</sup>Tc-HMPAO Using Leukokit® with Gelofusine versus Leukokit® with HES as Sedimentation Agent

<div>RBC and PLT contamination when using HES, Gelofusine, or control (0.9% NaCl) before and after GR isolation (error bars = SE).</div>

Contrast Media & Molecular Imaging

fig2

Figure 2

Figure 2: Labelling and Clinical Performance of Human Leukocytes Labelled with <sup>99m</sup>Tc-HMPAO Using Leukokit® with Gelofusine versus Leukokit® with HES as Sedimentation Agent 

Figure 2 | Labelling and Clinical Performance of Human Leukocytes Labelled with 99mTc-HMPAO Using Leukokit® with Gelofusine versus Leukokit® with HES as Sedimentation Agent 